Fulgent Investment Development Limited entered into an agreement to acquire 40.5% stake in Fujian Fujun Gene Biotechnology Co., Ltd. from Xilong Scientific Co., Ltd. (SZSE:002584) for approximately CNY 120 million on May 7, 2021. The board of Xilong Scientific approved the transaction. As of March 31, 2021, Fujian Fujun Gene Biotechnology recorded total assets of CNY 67.5 million and net assets of CNY 9.2 million.